title: Serum miR-21 levels in patients with dermatomyositis.
authors.forename: Shuichi
authors.initials: S
authors.lastname: Shimada
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Jinnin
authors.forename: Aki
authors.initials: A
authors.lastname: Ogata
authors.forename: Takamitsu
authors.initials: T
authors.lastname: Makino
authors.forename: Ikko
authors.initials: I
authors.lastname: Kajihara
authors.forename: Katsunari
authors.initials: K
authors.lastname: Makino
authors.forename: Noritoshi
authors.initials: N
authors.lastname: Honda
authors.forename: Wakana
authors.initials: W
authors.lastname: Nakayama
authors.forename: Kuniko
authors.initials: K
authors.lastname: Inoue
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fukushima
authors.forename: Hironobu
authors.initials: H
authors.lastname: Ihn
mesh_terms: D016022:Case-Control Studies; D003882:Dermatomyositis / Q000097:blood / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000097:blood*; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D015854:Up-Regulation
chemical_list: D005819:Genetic Markers; C524940:MIRN21 microRNA, human; D035683:MicroRNAs